Targeting STAT3 in Cancer Immunotherapy
2020 · Molecular Cancer · 1,000 citations
https://doi.org/10.1186/s12943-020-01258-7
S
Sailan Zou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
1.5K
Citations
10
h-index
10
i10-index
Sailan Zou is an academic researcher from Sichuan University. The author has contributed to research in topics: MicroRNA in disease regulation & RNA modifications and cancer & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 10, co-authored 12 publications.
ORCID: 0000-0002-0371-248XPapers by this author
worksThe pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation
2019 · Molecular Metabolism · 108 citations
https://doi.org/10.1016/j.molmet.2019.02.003
UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination
2022 · Oncogene · 26 citations
https://doi.org/10.1038/s41388-022-02509-1
A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells
2022 · Molecular Therapy — Nucleic Acids · 12 citations
https://doi.org/10.1016/j.omtn.2022.08.036
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat